MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2022 International Congress

    A Patient-Centered Outcomes Survey in Parkinson’s Disease: Results of Cognitive Pre-Testing

    D. Shah-Zamora, J. Karl, M. Tosin, G. Pal, G. Stebbins, C. Goetz, L. Verhagen (Chicago, USA)

    Objective: To validate the Rush Parkinson's Disease Patient-Centered Outcomes Questionnaire (RUSH-PCO-Q). Background: The RUSH-PCO-Q aims to address the lack of patient-centered outcomes in the field…
  • 2022 International Congress

    Continuous wavelet transforms to improve the accuracy of motor assessments of Parkinson’s disease

    T. Kosuri, J. Brasic (Baltimore, USA)

    Objective: We sought to develop a protocol to utilize continuous wavelet transforms (CWTs) to rate the severity of movements to obtain optimal classifications of PD.…
  • 2022 International Congress

    Development of a quality-of-life (QoL) questionnaire for hereditary spastic paraplegia (HSP) patients and caregivers.

    J. Malina, B. Schröder, E. Hüßler, T. Kühl, S. Klebe (Essen, Germany)

    Objective: Patient reported outcomes like “Health-Related Quality of Life” are one of the key outcome parameters of clinical studies. The aim of this project within…
  • 2022 International Congress

    Socio-economic factors influencing Parkinson’s disease self-management

    L. Ambrosio, C. Rodríguez-Blazquez, M. Rodriguez Violante, T. Arakaki, N. Garretto, M. Serrano-Dueñas, I. Ibañez (Southampton, United Kingdom)

    Objective: To identify the socioeconomical factors associated with self-management Parkinson’s disease (PD). Background: Understanding and evaluating how PD patients manage their disease is paramount to…
  • 2022 International Congress

    A modified Delphi panel to establish a threshold of meaningful progression on MDS-UPDRS Part III

    D. Trundell, L. Barrett, R. Rogers, E. Davies, S. Zanigni, N. Pross, G. Pagano, T. Nikolcheva, S. Cano (Welwyn Garden City, United Kingdom)

    Objective: To establish a threshold for meaningful progression on MDS-UPDRS Part III in an early-stage Parkinson's disease (PD) population (Hoehn & Yahr [H&Y] Stage I–II)…
  • 2022 International Congress

    Updated Parkinson’s disease motor subtypes classification and correlation to CSF HVA and 5-HIAA levels

    M. Schiess, J. Suescun, A. Haque, K. Block, E. Tharp, T. Ellmore, C. Adams (Houston, USA)

    Objective: To update a motor subtypes classification using the MDS-UPDRS and determine if CSF neurotransmitter profiles (HVA and 5-HIAA) are different between MDS-UPDRS subtypes in…
  • 2022 International Congress

    Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease

    Y. Dushin, G. Morinan, G. Sarapata, J. O'Keeffe (London, United Kingdom)

    Objective: To develop a scalable and interpretable computer-vision based algorithm to measure the severity of facial impairment in Parkinson’s disease. Background: Neurological disorders frequently manifest…
  • 2022 International Congress

    Blood microRNA-7 as a Progression Biomarker in Parkinson’s disease

    M. Doursout, C. Adams, J. Suescun, K. Block, E. Tharp, T. Ellmore, M. Schiess (Houston, USA)

    Objective: This study investigates the use of microRNA-7-5p (miR-7-5p) as a potential biomarker for Parkinson’s disease (PD) progression. Background: MiR-7-5 is a microRNA that regulates…
  • 2022 International Congress

    Studies on stigma in Parkinson’s disease in the world. A literature review

    S. Kibrit, AV. Karacan, G. Kayis, R. Yilmaz, MC. Akbostancı (Ankara, Turkey)

    Objective: To demonstrate the geographical distribution of studies among populations, and to summarize factors associated with stigma in Parkinson’s disease (PD). Background: One of the…
  • 2022 International Congress

    Remission of Gilles de la Tourette Syndrome Following Dehydration

    A. Durbin, M. Rodgers, J. Brasic, D. Wong (Baltimore, USA)

    Objective: To assess the beneficial and adverse effects of heat on a man with Gilles de la Tourette Syndrome (TS) Background: The effect of heat…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley